Checked.be
Active
BE 0403.088.151Public limited company
ROCHE
Dantestraat 75 ·1070 Anderlecht, Belgium· 102 yrs active
Sector: NACE 21201
(21201)
Conclusion
The computed 12-month bankruptcy probability of ROCHE is 0.6% (low). The company has been active since 1924 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Key figures
| Active | 102 yrs |
| Board | 4 |
| Locations | 2 |
| Publications | 44 |
Bankruptcy probability (12 mo)
0.6%
Low
0%0,5%1,5%4%10%≥25%
Long track record
−Higher-failure-rate region
+Multiple establishment units
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Risk Assessment
0 / 100
Low riskTrust signals
Long-established
Founded in 1924, 102 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No administrative flags
Financial overview
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2025 (volledig). The annual accounts are being processed.
Filings on record
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 09-06-2026 | 2026-00148910 |
| 31-12-2024 | volledig | 17-06-2025 | 2025-00143701 |
| 31-12-2023 | volledig | 10-06-2024 | 2024-00117960 |
| 31-12-2022 | volledig | 09-05-2023 | 2023-00085083 |
| 31-12-2021 | volledig | 29-04-2022 | 2022-20016425 |
| 31-12-2020 | volledig | 28-04-2021 | 2021-11600579 |
| 31-12-2019 | volledig | 07-05-2020 | 2020-11800451 |
| 31-12-2018 | volledig | 29-04-2019 | 2019-10900446 |
| 31-12-2017 | volledig | 03-05-2018 | 2018-12200529 |
| 31-12-2016 | volledig | 28-04-2017 | 2017-10900117 |
Directors & mandates
Current directors & mandates
-
Current01-11-2022 → present
-
Current01-07-2022 → present
-
Current01-05-2022 → present
2 events
- 01-05-2022 Appointed· Director
- 01-05-2022 Appointed· Managing director
-
Current01-03-2022 → present
Historic, not recently confirmed (8)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
-
Not recently confirmedlast confirmed in an act from 2020
-
Not recently confirmedlast confirmed in an act from 2017
-
Not recently confirmedlast confirmed in an act from 2014
-
Not recently confirmedlast confirmed in an act from 2013
4 events
- 26-06-2013 Mandate renewed· Director
- 01-06-2013 Resigned· Director
- 21-02-2013 Appointed· Director
- 24-12-2007 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2007
2 events
- 24-12-2007 Mandate renewed· Director
- 11-07-2005 Mandate renewed· Managing director
-
Not recently confirmedlast confirmed in an act from 2007
-
Not recently confirmedlast confirmed in an act from 2007
2 events
- 24-12-2007 Mandate renewed· Director
- 11-07-2005 Mandate renewed· Director
-
Not recently confirmedlast confirmed in an act from 2005
Former directors (14)
-
Former- → 06-06-2024
-
Former- → 01-11-2022
-
Former10-11-2021 → 01-07-2022
2 events
- 01-07-2022 Resigned· Director
- 10-11-2021 Appointed· Director
-
Former- → 01-05-2022
-
Former01-12-2018 → 01-03-2022
3 events
- 01-03-2022 Resigned· Daily management
- 01-12-2018 Appointed· Director
- 01-12-2018 Appointed· Managing director
-
Former- → 10-11-2021
-
Former26-06-2013 → 01-01-2020
5 events
- 01-01-2020 Resigned· Director
- 10-03-2014 Appointed· Director
- 01-09-2013 Resigned· Director
- 26-06-2013 Mandate renewed· Director
- 25-04-2013 Resigned· Managing director
-
Former01-01-2016 → 01-12-2018
4 events
- 01-12-2018 Resigned· Director
- 01-12-2018 Resigned· Managing director
- 01-01-2016 Appointed· Director
- 01-01-2016 Appointed· Managing director
-
Former01-06-2013 → 01-04-2017
2 events
- 01-04-2017 Resigned· Director
- 01-06-2013 Appointed· Director
-
Former01-09-2015 → 01-01-2016
2 events
- 01-01-2016 Resigned· Director
- 01-09-2015 Appointed· Director
-
Former25-04-2013 → 01-09-2015
3 events
- 01-09-2015 Resigned· Director
- 01-09-2015 Resigned· Managing director
- 25-04-2013 Appointed· Director
-
Former01-09-2013 → 10-03-2014
2 events
- 10-03-2014 Resigned· Director
- 01-09-2013 Appointed· Director
-
Former- → 11-02-2013
-
Former- → 24-12-2007
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| KPMG Bedrijfsrevisoren BV/SRLCurrent Statutory auditor · represented by Ellemarie Bex |
- | 28-11-2025 → present |
| Klynveld Peat Marwick Goerdeler - Réviseurs d'Entreprises SCRL Civile Statutory auditor · represented by Karel Tanghe |
- | - → 15-06-2011 |
| KPMG Bedrijfsrevisoren CVBA Statutory auditor · represented by Olivier Declercq succeeded by KPMG BEDRIJFSREVISOREN REVISEURS D'ENTREPRISE SCRL in 2016 |
- | 24-12-2007 → 03-06-2016 |
| KPMG BEDRIJFSREVISOREN REVISEURS D'ENTREPRISE BV/SRL Statutory auditor · represented by Tanguy Legein succeeded by KPMG Bedrijfsrevisoren BV/SRL in 2025 |
- | 30-06-2023 → 28-11-2025 |
| KPMG BEDRIJFSREVISOREN REVISEURS D'ENTREPRISE SCRL Statutory auditor · represented by Axel Jorion succeeded by KPMG BEDRIJFSREVISOREN REVISEURS D'ENTREPRISE BV/SRL in 2023 |
- | 03-06-2016 → 30-06-2023 |
| KPMG Réviseurs d'Entreprises SCRL civile Statutory auditor · represented by Axel Jorion succeeded by KPMG BEDRIJFSREVISOREN REVISEURS D'ENTREPRISE BV/SRL in 2023 |
- | 31-05-2017 → 30-06-2023 |
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
| NACE primary | 21201 |
| Legal form | Public limited company(014) |
| Incorporation | 12-02-1924 |
| Status | Active |
| Postal code | 1070 |
Establishment units
Dantestraat 75, 1070 Anderlecht
since 19242.003.056.631
Berkenlaan 8A, 1831 Machelen (Brab.)
since 20252.378.693.287
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21306C0225/00C002 | Brussels | 1.2 ha | 1 · 1,356 m² | 19.1 m · 5 fl. |
| 23015B0120/00E000 | Flanders | 9,322 m² | 1 · 1,390 m² | 26.6 m · 7 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2026
09-06-2026
NBB filing
Annual accounts filed
2025
28-11-2025
State Gazette act
Director changes
22-07-2025
State Gazette act
Verified v1
17-06-2025
NBB filing
Annual accounts filed
31-01-2025
State Gazette act
Director changes
2024
18-07-2024
State Gazette act
Director changes
10-06-2024
NBB filing
Annual accounts filed
19-04-2024
State Gazette act
Director changes
19-01-2024
State Gazette act
Statutes amendment
2023
30-06-2023
State Gazette act
Director changes
09-05-2023
NBB filing
Annual accounts filed
04-01-2023
State Gazette act
Director changes
2022
29-04-2022
NBB filing
Annual accounts filed
18-03-2022
State Gazette act
Director changes
17-01-2022
State Gazette act
Director changes
2021
19-11-2021
State Gazette act
Director changes
28-04-2021
NBB filing
Annual accounts filed
25-02-2021
State Gazette act
Director changes
2020
07-08-2020
State Gazette act
Director changes
07-05-2020
NBB filing
Annual accounts filed
16-03-2020
State Gazette act
Director changes
2019
17-12-2019
State Gazette act
Director changes
12-08-2019
State Gazette act
Director changes
09-07-2019
State Gazette act
Verified v1
09-07-2019
State Gazette act
Verified v1
29-04-2019
NBB filing
Annual accounts filed
15-03-2019
State Gazette act
Director changes
18-01-2019
State Gazette act
Director changes
2018
06-11-2018
State Gazette act
Director changes
03-05-2018
NBB filing
Annual accounts filed
2017
02-10-2017
State Gazette act
Director changes
20-06-2017
State Gazette act
Director changes
22-05-2017
State Gazette act
Director changes
28-04-2017
NBB filing
Annual accounts filed
2016
03-06-2016
State Gazette act
Director changes
11-05-2016
State Gazette act
Verified v1
01-03-2016
State Gazette act
Director changes
2015
13-11-2015
State Gazette act
Director changes
27-01-2015
State Gazette act
Director changes
2014
02-12-2014
State Gazette act
Director changes
18-03-2014
State Gazette act
Director changes
10-03-2014
State Gazette act
Director changes
2013
22-11-2013
State Gazette act
Director changes
22-11-2013
State Gazette act
Director changes
26-06-2013
State Gazette act
Director changes
05-06-2013
State Gazette act
Director changes
19-03-2013
State Gazette act
Director changes
2011
15-06-2011
State Gazette act
Director changes
15-06-2011
State Gazette act
Director changes
03-05-2011
State Gazette act
Verified v1
2007
24-12-2007
State Gazette act
Director changes
24-12-2007
State Gazette act
Director changes
2005
11-07-2005
State Gazette act
Director changes
2004
06-12-2004
State Gazette act
Director changes
Belgisch Staatsblad, acts
All acts · 44
updated 8 months ago
2025
28-11-2025 Ellemarie Bex reappointed as statutory auditor
- Ellemarie Bex, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ellemarie Bex",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "KPMG Bedrijfsrevisoren BV/SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De aandeelhouders beslissen unaniem om het mandaat te hernieuwen van de vennootschap KPMG Bedrijfsrevisoren BV/SRL, gevestigd te 1930 Zaventem, Luchthaven Brussel Nationaal 1K, als commissaris van Roche NV, met als vaste vertegenwoordiger mevrouw Ellemarie Bex, bedrijfsrevisor."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "NV"
}
}22-07-2025 Board meeting · Statute amendment · General meeting · Officer appointment
- Publication: 22/07/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 11/07/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Board meeting: 23/04/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Statute amendment: wijziging delegatiereglement dagelijks bestuur · Algemene Vereniging van de Geneesmiddelenindustrie
- General meeting: 11/06/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Almirall N.V.
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Novo Nordisk Pharma N.V.
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Takeda Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · Amgen N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · MSD Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · Roche N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · UCB Pharma N.V.
- Officer resignation: role: bestuurder, end_date: 2025-06-11 · Vertex Pharmaceuticals (Netherlands) BV
- Permanent representative: start_date: 16/05/2025 · Paul Lacante
- Permanent representative · Gregory Paton
- Permanent representative · Axel De Muyt
- Permanent representative · Bruno Rabilier
Summary:
Board meeting · Statute amendment · General meeting · Officer appointment
Technical details
{
"facts": [
{
"date": "2025-07-22",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad -22/07/2025 - Annexes du Moniteur belge",
"value": "22/07/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-07-11",
"type": "filing",
"quote": "neergelegd/ontvangen op 114 JULI 2025",
"value": "11/07/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-04-23",
"type": "board_meeting",
"quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 23 APRIL 2025",
"value": "23/04/2025",
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "Onderwerp akte: Benoeming bestuurders - wijziging delegatiereglement dagelijks bestuur",
"value": "wijziging delegatiereglement dagelijks bestuur",
"object": null,
"subject": "e1"
},
{
"date": "2025-06-11",
"type": "general_meeting",
"quote": "GEWONE ALGEMENE VERGADERING VAN 11 JUNI 2025",
"value": "11/06/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Almirall N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Novo Nordisk Pharma N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Takeda Belgium N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 1. Amgen N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 2. MSD Belgium N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e6",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 3. Roche N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e7",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 4. UCB Pharma N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e8",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"type": "officer_resignation",
"quote": "Ontslag van: 1. Vertex Pharmaceuticals (Netherlands) BV",
"value": {
"role": "bestuurder",
"end_date": "2025-06-11"
},
"object": null,
"subject": "e9",
"_value_raw": {
"role": "bestuurder",
"reason": "ontslag",
"end_date": "11/06/2025"
}
},
{
"date": "2025-05-16",
"type": "permanent_representative",
"quote": "Bristol-Myers Squibb Belgium N.V. ... heeft als nieuwe vaste vertegenwoordiger vanaf 16/05/2025 de heer Paul Lacante",
"value": {
"start_date": "16/05/2025"
},
"object": "e10",
"subject": "e11"
},
{
"type": "permanent_representative",
"quote": "Almirall N.V. ... heeft als vaste vertegenwoordiger de heer Gregory Paton",
"value": {},
"object": "e2",
"subject": "e13"
},
{
"type": "permanent_representative",
"quote": "Novo Nordisk Pharma N.V. ... heeft als vaste vertegenwoordiger de heer Axel De Muyt",
"value": {},
"object": "e3",
"subject": "e14"
},
{
"type": "permanent_representative",
"quote": "Takeda Belgium N.V. ... heeft als vaste vertegenwoordiger de heer Bruno Rabilier",
"value": {},
"object": "e4",
"subject": "e15"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 9714,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Kantersteen 47, 1000 Brussel",
"legal_form": "Vereniging zonder Winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e2",
"kbo": "0403.090.131",
"kind": "company",
"name": "Almirall N.V.",
"attrs": {
"seat": "Lenneke Marelaan 4, 1932 Sint-Stevens-Woluwe"
}
},
{
"id": "e3",
"kbo": "0414.695.586",
"kind": "company",
"name": "Novo Nordisk Pharma N.V.",
"attrs": {
"seat": "Alfons Gossetlaan 32E/202, 1702 Groot-Bijgaarden"
}
},
{
"id": "e4",
"kbo": "0403.054.202",
"kind": "company",
"name": "Takeda Belgium N.V.",
"attrs": {
"seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
}
},
{
"id": "e5",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen N.V.",
"attrs": {
"seat": "Telecomlaan 5-7, 1831 Diegem"
}
},
{
"id": "e6",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium N.V.",
"attrs": {
"seat": "Vorstlaan 25, 1170 Watermaal-Bosvoorde"
}
},
{
"id": "e7",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche N.V.",
"attrs": {
"seat": "Dantestraat 75, 1070 Anderlecht"
}
},
{
"id": "e8",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma N.V.",
"attrs": {
"seat": "Researchdreef 60, 1070 Anderlecht"
}
},
{
"id": "e9",
"kbo": "0666.408.905",
"kind": "company",
"name": "Vertex Pharmaceuticals (Netherlands) BV",
"attrs": {
"seat": "Leidsevaart 20, NL - 2013 HA Haarlem"
}
},
{
"id": "e10",
"kbo": "0403.075.184",
"kind": "company",
"name": "Bristol-Myers Squibb Belgium N.V.",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Paul Lacante",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Sally McNab",
"attrs": {}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Gregory Paton",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Axel De Muyt",
"attrs": {}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Bruno Rabilier",
"attrs": {}
},
{
"id": "e16",
"kbo": null,
"kind": "company",
"name": "Facing BV",
"attrs": {}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {}
}
]
}31-01-2025 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "NV"
}
}2024
18-07-2024 Tanguy Legein resigns as permanent representative
- Tanguy Legein, Vaste vertegenwoordiger
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Tanguy Legein",
"address": null,
"birth_date": null
},
"effective_date": "2024-06-06",
"evidence_quote": "De aandeelhouders hebben kennis genomen van het feit dat KPMG Bedrijfsrevisoren BV/SRL, de commissaris van Roche NV/SA, besloten heeft om Tanguy Legein met onmiddellijke ingang te vervangen door Ellemarie Bex, bedrijfsrevisor, als haar vaste vertegenwoordiger."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "NV"
}
}19-04-2024 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "NV"
}
}19-01-2024 Articles of association amended
Summary:
v3.2
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2023-12-14",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}2023
30-06-2023 Tanguy Legein reappointed as statutory auditor
- Tanguy Legein, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Tanguy Legein",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "KPMG BEDRIJFSREVISOREN REVISEURS D\u0027ENTREPRISE BV/SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027Assembl\u00E9e proc\u00E8de \u00E0 la r\u00E9\u00E9lection de Monsieur Tanguy Legein (r\u00E9viseur d\u0027entreprises) comme repr\u00E9sentant du commissaire, la soci\u00E9t\u00E9 KPMG BEDRIJFSREVISOREN REVISEURS D\u0027ENTREPRISE BV/SRL pour une dur\u00E9e de trois (3) ans, soit pour les exercices 2022, 2023, et 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}04-01-2023 4 directors appointed, 3 resigning
- Maria Johanna Borst, Bestuurder
- Maria Johanna Borst, Gedelegeerd bestuurder
- Isabelle Decker, Bestuurder
- Isabel Boissonnas, Bestuurder
- Ehab Youssef, Gedelegeerd bestuurder
- Harald Borrmann, Bestuurder
- Beat Krähenmann, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Maria Johanna Borst",
"address": null,
"birth_date": null
},
"effective_date": "2022-05-01",
"evidence_quote": "Les Actionnaires d\u00E9cident de nommer Maria Johanna Borst, r\u00E9sidant \u00E0 H\u00F6lzlistrasse 46, 4102 Binningen (Suisse), en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 1 Mai 2022."
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Ehab Youssef",
"address": null,
"birth_date": null
},
"effective_date": "2022-05-01",
"evidence_quote": "Le Conseil prend acte de la d\u00E9mission en qualit\u00E9 d\u0027administrateur d\u00E9l\u00E9gu\u00E9 de Ehab Youssef, avec effet au 1 Mai 2022."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Maria Johanna Borst",
"address": null,
"birth_date": null
},
"effective_date": "2022-05-01",
"evidence_quote": "Le Conseil d\u00E9cide de nommer administrateur Maria Johanna Borst, r\u00E9sidant \u00E0 H\u00F6lzlistrasse 46, 4102 Binningen (Suisse) en qualit\u00E9 d\u0027administrateur d\u00E9l\u00E9gu\u00E9 de la Soci\u00E9t\u00E9, avec effet au 1 Mai 2022."
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Harald Borrmann",
"address": null,
"birth_date": null
},
"effective_date": "2022-07-01",
"evidence_quote": "Les Actlonnaires prennent acte de la d\u00E9mission en quallt\u00E9 d\u0027administrateur de Harald Borrmann, avec effet au 1 Juillet 2022."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Isabelle Decker",
"address": null,
"birth_date": null
},
"effective_date": "2022-07-01",
"evidence_quote": "Les Actionnaires d\u00E9cident de nommer Isabelle Decker, r\u00E9sidant \u00E0 R\u00FCtirainstrasse 16, 6344 Meierskappel (Suisse), en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 1 Juillet 2022."
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Beat Kr\u00E4henmann",
"address": null,
"birth_date": null
},
"effective_date": "2022-11-01",
"evidence_quote": "Les Actionnaires prennent acte de la d\u00E9mission en qualit\u00E9 d\u0027administrateur de Beat Kr\u00E4henmann avec effet! au 1 Novembre 2022."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Isabel Boissonnas",
"address": null,
"birth_date": null
},
"effective_date": "2022-11-01",
"evidence_quote": "Les Actionnaires d\u00E9cident de nommer Isabel Boissonnas, r\u00E9sidant \u00E0 Bohlstrasse 29, 6300 Zug (Suisse), en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 1 Novembre 2022."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}2022
18-03-2022 1 director appointed, 1 resigning, 1 reappointed
- Ehab Abdelmoneim Youssef, Dagelijks bestuur
- Brigitte Nolet, Dagelijks bestuur
- Tanguy Legein, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Brigitte Nolet",
"address": null,
"birth_date": null
},
"effective_date": "2022-03-01",
"evidence_quote": "Le Conseil prend acte de la d\u00E9mission en qualit\u00E9 d\u0027administrateur d\u00E9l\u00E9gu\u00E9 de Brigitte Nolet, avec effet au 1 Mars 2022."
},
{
"kind": "director_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Ehab Abdelmoneim Youssef",
"address": null,
"birth_date": null
},
"effective_date": "2022-03-01",
"evidence_quote": "Le Conseil d\u00E9cide de nommer administrateur Ehab Abdelmoneim Youssef, Grenzacherstrasse 32, 4058 Basel en qualit\u00E9 d\u0027administrateur d\u00E9l\u00E9gu\u00E9 de la Soci\u00E9t\u00E9, avec effet au 1 Mars 2022."
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Tanguy Legein",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0403088151",
"name": "KPMG R\u00E9viseurs d\u0027Entreprises BV/SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2021-11-23",
"evidence_quote": "Le Conseil a pris connaissance du fait que la soci\u00E9t\u00E9 KPMG R\u00E9viseurs d\u0027Entreprises BV/SRL commissaire de Roche SA/NV a d\u00E9cid\u00E9 de remplacer Axel Jorion par Tanguy Legein, r\u00E9viseur d\u0027entreprises, en tant que repr\u00E9sentant permanent avec effet \u00E0 partir du 23 novembre 2021"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}17-01-2022 1 director appointed, 1 resigning
- Harald Borrmann, Bestuurder
- Anna-Maria Heuchel-Reinig, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Anna-Maria Heuchel-Reinig",
"address": null,
"birth_date": null
},
"effective_date": "2021-11-10",
"evidence_quote": "Les Actionnaires prennent acte de la d\u00E9mission en qualit\u00E9 d\u0027administrateur de Anna-Maria Heuchel-Reinig, avec effet au 10 novembre 2021."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Harald Borrmann",
"address": null,
"birth_date": null
},
"effective_date": "2021-11-10",
"evidence_quote": "Les Actionnaires d\u00E9cident de nommer Harald Borrmann, r\u00E9sidant \u00E0 Pannerhofstrasse 19, 6353 Weggis (Suisse), en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 10 novembre 2021."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}2021
19-11-2021 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}25-02-2021 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}2020
07-08-2020 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}16-03-2020 1 director appointed, 1 resigning
- Ehab Yousef, Bestuurder
- Luc Dirckx, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Luc Dirckx",
"address": null,
"birth_date": null
},
"effective_date": "2020-01-01",
"evidence_quote": "PREND ACTE de la d\u00E9mission de Monsieur Luc Dirckx comme Administrateur de la Soci\u00E9t\u00E9, cette d\u00E9mission prenant effet le 1 Janvier 2020."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ehab Yousef",
"address": null,
"birth_date": null
},
"effective_date": "2020-01-01",
"evidence_quote": "DECIDE de nommer Monsieur Ehab Yousef avec r\u00E9sidence \u00E0 Grenzacherstrasse 32, 4058 Basel en qualit\u00E9 d\u0027Administrateur de la Soci\u00E9t\u00E9, cette ncmination prenant effet le 1 Janvier 2020."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}2019
17-12-2019 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}12-08-2019 Axel Jorion reappointed as statutory auditor
- Axel Jorion, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Axel Jorion",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "KPMG BEDRIJFSREVISOREN REVISEURS D\u0027ENTREPRISE SCRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027Assembl\u00E9e proc\u00E8de \u00E0 la r\u00E9\u00E9lection de Monsieur Axel Jorion (r\u00E9viseur d\u0027entreprises, membre A02363) comme repr\u00E9sentant du commissaire, la soci\u00E9t\u00E9 KPMG BEDRIJFSREVISOREN REV\u0130SEURS D\u0027ENTREPRISE SCRL pour une dur\u00E9e de trois (3) ans, soit pour les exercices 2019, 2020, et 2021."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}09-07-2019 General meeting · Officer reappointment · Board meeting · Officer appointment
- Publication: 09/07/2019
- Filing: 28/06/2019
- General meeting: 27/03/2019
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · MSD Belgium N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · Roche N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · Chiesi N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · UCB Pharma N.V.
- Board meeting: 24/04/2019
- Officer appointment: role: ondervoorzitter van de Raad van Bestuur, start_date: 2019-04-24 · Celgene
- Permanent representative · Michel Collard
- Officer resignation: date: 2019-04-24, role: ondervoorzitter van de Raad van Bestuur · MSD Belgium N.V.
- Permanent representative · Clarisse Lhoste
- Officer appointment: role: CEO belast met het dagelijks bestuur · Catherine Rutten
Summary:
General meeting · Officer reappointment · Board meeting · Officer appointment
Technical details
{
"facts": [
{
"date": "2019-07-09",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 09/07/2019",
"value": "09/07/2019",
"object": null,
"subject": null
},
{
"date": "2019-06-28",
"type": "filing",
"quote": "vangen op 28 JUNI 2019 ter griffie van de Nederlandstalige ondernemingsrechtbank Brusss",
"value": "28/06/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "general_meeting",
"quote": "ALGEMENE VERGADERING VAN 27 MAART 2019",
"value": "27/03/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 1. MSD Belgium N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e1",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 2. Roche N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e2",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 3. Chiesi N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e3",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 4. UCB Pharma N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e4",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-04-24",
"type": "board_meeting",
"quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 24 APRIL 2019",
"value": "24/04/2019",
"object": null,
"subject": null
},
{
"date": "2019-04-24",
"type": "officer_appointment",
"quote": "Op de Raad van Bestuur van 24 april 2019 werd Celgene, vertegenwoordigd door Michel Collard, verkozen tot nieuwe ondervoorzitter van de Raad van Bestuur",
"value": {
"role": "ondervoorzitter van de Raad van Bestuur",
"start_date": "2019-04-24"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "ondervoorzitter van de Raad van Bestuur",
"start_date": "24/04/2019"
}
},
{
"type": "permanent_representative",
"quote": "Celgene, vertegenwoordigd door Michel Collard",
"value": null,
"object": "e5",
"subject": "e6"
},
{
"date": "2019-04-24",
"type": "officer_resignation",
"quote": "in opvolging van MSD Belgium, vertegenwoordigd door Clarisse Lhoste",
"value": {
"date": "2019-04-24",
"role": "ondervoorzitter van de Raad van Bestuur"
},
"object": null,
"subject": "e1",
"_value_raw": {
"date": "24/04/2019",
"role": "ondervoorzitter van de Raad van Bestuur"
}
},
{
"type": "permanent_representative",
"quote": "MSD Belgium, vertegenwoordigd door Clarisse Lhoste",
"value": null,
"object": "e1",
"subject": "e7"
},
{
"type": "officer_appointment",
"quote": "Catherine Rutten CEO belast met het dagelijks bestuur",
"value": {
"role": "CEO belast met het dagelijks bestuur"
},
"object": null,
"subject": "e8"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1672,
"truncated": false
},
"entities": [
{
"id": "e0",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Terhulpsesteenweg 166, 1170 BRUSSEL",
"legal_form": "Vereniging zonder winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium N.V.",
"attrs": {
"seat": "Lynx Binnenhof 5, 1200 Sint-Lambrechts-Woluwe"
}
},
{
"id": "e2",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche N.V.",
"attrs": {
"seat": "Dantestraat 75, 1070 Anderlecht"
}
},
{
"id": "e3",
"kbo": "0826.654.883",
"kind": "company",
"name": "Chiesi N.V.",
"attrs": {
"seat": "Telecomlaan 9, 1831 Diegem"
}
},
{
"id": "e4",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma N.V.",
"attrs": {
"seat": "Researchdreef 60, 1070 Anderlecht"
}
},
{
"id": "e5",
"kbo": null,
"kind": "company",
"name": "Celgene",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Michel Collard",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Clarisse Lhoste",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {}
}
]
}09-07-2019 General meeting · Officer reappointment · Board meeting · Officer appointment
- Publication: 2019
- Filing: 28/05/2019
- General meeting: 27/03/2019
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · MSD Belgium S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · Roche S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · Chiesi S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · UCB Belgium S.A.
- Board meeting: 24/04/2019
- Officer appointment: role: Vice-Président du Conseil d'administration, start_date: 2019-04-24 · Celgene
- Permanent representative · Michel Collard
- Permanent representative · Clarisse Lhoste
Summary:
General meeting · Officer reappointment · Board meeting · Officer appointment
Technical details
{
"facts": [
{
"date": "2019-07-09",
"type": "publication",
"quote": "2019 - Annexes du Moniteur belge",
"value": "2019",
"object": null,
"subject": null
},
{
"date": "2019-05-28",
"type": "filing",
"quote": "neergelegd/ontvangen op 28 JUMM 2019",
"value": "28/05/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 27 MARS 2019",
"value": "27/03/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. MSD Belgium S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e1",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. Roche S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e2",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 3. Chiesi S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e3",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 4. UCB Belgium S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e4",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-04-24",
"type": "board_meeting",
"quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 24 AVRIL 2019",
"value": "24/04/2019",
"object": null,
"subject": null
},
{
"date": "2019-04-24",
"type": "officer_appointment",
"quote": "Celgene ... a \u00E9t\u00E9 \u00E9lue nouveau Vice-Pr\u00E9sident du Conseil d\u0027administration",
"value": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"start_date": "2019-04-24"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"start_date": "24/04/2019"
}
},
{
"type": "permanent_representative",
"quote": "Celgene, repr\u00E9sent\u00E9e par Michel Collard",
"value": null,
"object": "e5",
"subject": "e6"
},
{
"type": "permanent_representative",
"quote": "MSD Belgium, repr\u00E9sent\u00E9e par Clarisse Lhoste",
"value": null,
"object": "e1",
"subject": "e7"
}
],
"act_meta": {
"outcome": "corrected",
"postfix": [
"publication date None -\u003E edition 2019-07-09"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1695,
"truncated": false
},
"entities": [
{
"id": "e0",
"kbo": "0407.622.902",
"kind": "company",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium S.A.",
"attrs": {
"seat": "Clos du Lynx 5, 1200 Woluwe-Saint-Lambert"
}
},
{
"id": "e2",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche S.A.",
"attrs": {
"seat": "rue Dante 75, 1070 Anderlecht"
}
},
{
"id": "e3",
"kbo": "0826.654.883",
"kind": "company",
"name": "Chiesi S.A.",
"attrs": {
"seat": "Telecomlaan 9, 1831 Diegem"
}
},
{
"id": "e4",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Belgium S.A.",
"attrs": {
"seat": "All\u00E9e de la Recherche 60, 1070 Anderlecht"
}
},
{
"id": "e5",
"kbo": null,
"kind": "company",
"name": "Celgene",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Michel Collard",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Clarisse Lhoste",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {}
}
]
}15-03-2019 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}18-01-2019 2 directors appointed, 2 resigning
- Brigitte Nolet, Bestuurder
- Brigitte Nolet, Gedelegeerd bestuurder
- Priya Ratnam, Bestuurder
- Priya Ratnam, Gedelegeerd bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Priya Ratnam",
"address": null,
"birth_date": null
},
"effective_date": "2018-12-01",
"evidence_quote": "L\u0027assembl\u00E9e prend acte de la d\u00E9mission de Madame Priya Ratnam de son mandat d\u0027Administrateur et d\u0027Administrateur D\u00E9l\u00E9gu\u00E9, cette d\u00E9mission prenant effet le 1 D\u00E9cembre 2018."
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Priya Ratnam",
"address": null,
"birth_date": null
},
"effective_date": "2018-12-01",
"evidence_quote": "L\u0027assembl\u00E9e prend acte de la d\u00E9mission de Madame Priya Ratnam de son mandat d\u0027Administrateur et d\u0027Administrateur D\u00E9l\u00E9gu\u00E9, cette d\u00E9mission prenant effet le 1 D\u00E9cembre 2018."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Brigitte Nolet",
"address": null,
"birth_date": null
},
"effective_date": "2018-12-01",
"evidence_quote": "L\u0027assembl\u00E9e decide de nommer Brigitte Nolet avec r\u00E9sidence \u00E0 4 Grange Rd, London, England, W55BX qualit\u00E9 d\u0027Administrateur et d\u0027Administrateur D\u00E9l\u00E9gu\u00E9, cette nomination prenant effet le 1 D\u00E9cembre 2018 pour une dur\u00E9e ind\u00E9termin\u00E9e."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Brigitte Nolet",
"address": null,
"birth_date": null
},
"effective_date": "2018-12-01",
"evidence_quote": "L\u0027assembl\u00E9e decide de nommer Brigitte Nolet avec r\u00E9sidence \u00E0 4 Grange Rd, London, England, W55BX qualit\u00E9 d\u0027Administrateur et d\u0027Administrateur D\u00E9l\u00E9gu\u00E9, cette nomination prenant effet le 1 D\u00E9cembre 2018 pour une dur\u00E9e ind\u00E9termin\u00E9e."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}2018
06-11-2018 1 director appointed, 1 resigning
- Axel Jorion, Commissaris
- Olivier Declercq, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Olivier Declercq",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "KPMG R\u00E9viseurs d\u0027Entreprises SCRL Civile",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2017-05-31",
"evidence_quote": "Le conseil d\u0027administrateurs a pris connaissance du fait que la soci\u00E9t\u00E9 KPMG R\u00E9viseurs d\u0027Entreprises SCRL Civile a d\u00E9cid\u00E9 de remplacer Olivier Declercq par Axel Jorion, r\u00E9viseur d\u0027entreprises, en tant que repr\u00E9sentant permanent du commissaire avec effet \u00E0 partir de l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui s\u0027est pro"
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Axel Jorion",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "KPMG R\u00E9viseurs d\u0027Entreprises SCRL Civile",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2017-05-31",
"evidence_quote": "Le conseil d\u0027administrateurs a pris connaissance du fait que la soci\u00E9t\u00E9 KPMG R\u00E9viseurs d\u0027Entreprises SCRL Civile a d\u00E9cid\u00E9 de remplacer Olivier Declercq par Axel Jorion, r\u00E9viseur d\u0027entreprises, en tant que repr\u00E9sentant permanent du commissaire avec effet \u00E0 partir de l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui s\u0027est pro"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}2017
02-10-2017 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}20-06-2017 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}22-05-2017 1 director appointed, 1 resigning
- Anna-Maria REINIG, Bestuurder
- Uta-Maria OHNDORF, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Uta-Maria OHNDORF",
"address": null,
"birth_date": null
},
"effective_date": "2017-04-01",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de prendre acte de la d\u00E9mission de Madame Uta-Maria OHNDORF en tant qu\u0027Administrateur avec effet au 01 Avril 2017. L\u0027assembl\u00E9e donne d\u00E9charge \u00E0 l\u0027Administrateur pour sa gestion en 2016.",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Anna-Maria REINIG",
"address": null,
"birth_date": null
},
"effective_date": "2017-04-01",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer Madame Anna-Maria REINIG, avec r\u00E9sidence \u00E0 Stra\u017Ena 9/H, 831 01 Bratislava, Slovaquie en tant qu\u0027Administrateur avec effet au 1 Avril 2017 pour une dur\u00E9e ind\u00E9termin\u00E9e."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}2016
03-06-2016 Olivier Declercq reappointed as statutory auditor
- Olivier Declercq, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Olivier Declercq",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "KPMG BEDRIJFSREVISOREN REVISEURS D\u0027ENTREPRISE SCRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027Assembl\u00E9e proc\u00E8de \u00E0 la r\u00E9\u00E9lection de Monsieur Olivier Declercq (r\u00E9viseur d\u0027entreprises) comme repr\u00E9sentant du commissaire, la soci\u00E9t\u00E9 KPMG BEDRIJFSREVISOREN REVISEURS D\u0027ENTREPRISE SCRL pour une dur\u00E9e de trois (3) ans, soit pour les exercices 2016, 2017, et 2018."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}11-05-2016 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 11/05/2016 · Association Générale de l'Industrie du Médicament
- Filing: 29/04/2016 · Association Générale de l'Industrie du Médicament
- General meeting: 18/03/2016 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: administrateur, start_date: 2016-03-18 · Roche S.A.
- Officer appointment: role: administrateur, start_date: 2016-03-18 · Chiesi S.A.
- Officer reappointment: role: administrateur, start_date: 2016-03-18 · MSD Belgium S.A.
- Officer reappointment: role: administrateur, start_date: 2016-03-18 · UCB Belgium S.A.
- Officer resignation: date: 2016-03-18, role: administrateur · AstraZeneca S.A.
- Officer resignation: date: 2016-03-18, role: administrateur · Baxter Belgium SPRL
- Officer resignation: date: 2016-03-18, role: administrateur · Bracco Imaging Europe B.V.
- Statute amendment: article: 14, description: Poids des votes, procuration et procédure de vote · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 16, description: Composition du Conseil d'administration · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 21, description: Mandats · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 27ter, description: Organes (groupe pharma.be animal health) · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 33, description: Conditions d'admission et durée de mandat exceptionnelle · Association Générale de l'Industrie du Médicament
Summary:
General meeting · Officer appointment · Officer reappointment · Officer resignation
Technical details
{
"facts": [
{
"date": "2016-05-11",
"type": "publication",
"quote": "Bijlagen bij het Belgisch. Staatshlad -11/05/2016-",
"value": "11/05/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-04-29",
"type": "filing",
"quote": "neergelegd/entvangen op 29 APR, 2016",
"value": "29/04/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-03-18",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 18 MARS 2016",
"value": "18/03/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-03-18",
"type": "officer_appointment",
"quote": "Nomination de: 1. Roche S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_appointment",
"quote": "Nomination de: 2. Chiesi S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. MSD Belgium S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. UCB Belgium S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 1. AstraZeneca S.A.",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e6",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 2. Baxter Belgium SPRL",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e7",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 3. Bracco Imaging Europe B.V.",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e8",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"type": "statute_amendment",
"quote": "article 14. Poids des votes, procuration et proc\u00E9dure de vote",
"value": {
"article": "14",
"description": "Poids des votes, procuration et proc\u00E9dure de vote"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 16. Composition",
"value": {
"article": "16",
"description": "Composition du Conseil d\u0027administration"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 21. Mandats",
"value": {
"article": "21",
"description": "Mandats"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "Article 27ter. Organes",
"value": {
"article": "27ter",
"description": "Organes (groupe pharma.be animal health)"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 33.",
"value": {
"article": "33",
"description": "Conditions d\u0027admission et dur\u00E9e de mandat exceptionnelle"
},
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 16790,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e2",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche S.A.",
"attrs": {
"seat": "rue Dante 75, 1070 Anderlecht"
}
},
{
"id": "e3",
"kbo": "0826.654.883",
"kind": "company",
"name": "Chiesi S.A.",
"attrs": {
"seat": "avenue du Bourget 44, 1130 Haren (Bruxelles)"
}
},
{
"id": "e4",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium S.A.",
"attrs": {
"seat": "Clos du Lynx 5, 1200 Woluwe-Saint-Lambert"
}
},
{
"id": "e5",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Belgium S.A.",
"attrs": {
"seat": "All\u00E9e de la Recherche 60, 1070 Anderlecht"
}
},
{
"id": "e6",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca S.A.",
"attrs": {
"seat": "rue Egide Van Ophem 110, 1180 Uccle"
}
},
{
"id": "e7",
"kbo": "0861.155.805",
"kind": "company",
"name": "Baxter Belgium SPRL",
"attrs": {
"seat": "boulevard d\u0027Angleterre 2-4, 1420 Braine l\u0027Alleud"
}
},
{
"id": "e8",
"kbo": "0892.349.322",
"kind": "company",
"name": "Bracco Imaging Europe B.V.",
"attrs": {
"seat": "avenue Pasteur 6, 1300 Wavre"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {
"role": "CEO charg\u00E9 de la gestion journali\u00E8re"
}
}
]
}01-03-2016 2 directors appointed, 1 resigning
- Priya RATNAM, Bestuurder
- Priya RATNAM, Gedelegeerd bestuurder
- Arnaud GUILLAUME, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Arnaud GUILLAUME",
"address": null,
"birth_date": null
},
"effective_date": "2016-01-01",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de prendre acte de la d\u00E9mission de Monsieur Arnaud GUILLAUME en tant qu\u0027Administrateur et Pr\u00E9sident du Conseil d\u0027Administration de la Soci\u00E9t\u00E9 avec effet au 01 Janvier 2016. L\u0027assembl\u00E9e donne d\u00E9charge \u00E0 l\u0027Administrateur pour sa gestion en 2015.",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Priya RATNAM",
"address": null,
"birth_date": null
},
"effective_date": "2016-01-01",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer Madame Priya RATNAM, avec r\u00E9sidence \u00E0 4252 22nd Street San Francisco, CA 94172 USA, en tant qu\u0027Administrateur et Administrateur D\u00E9l\u00E9gu\u00E9 et Pr\u00E9sident du Conseil d\u0027Administration de la Soci\u00E9t\u00E9 avec effet au 1 Janvier 2016 pour une dur\u00E9e ind\u00E9termin\u00E9e."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Priya RATNAM",
"address": null,
"birth_date": null
},
"effective_date": "2016-01-01",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer Madame Priya RATNAM, avec r\u00E9sidence \u00E0 4252 22nd Street San Francisco, CA 94172 USA, en tant qu\u0027Administrateur et Administrateur D\u00E9l\u00E9gu\u00E9 et Pr\u00E9sident du Conseil d\u0027Administration de la Soci\u00E9t\u00E9 avec effet au 1 Janvier 2016 pour une dur\u00E9e ind\u00E9termin\u00E9e."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}2015
13-11-2015 1 director appointed, 2 resigning
- GUILLAUME Arnaud, Bestuurder
- ERWIN Richard, Bestuurder
- ERWIN Richard, Gedelegeerd bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "ERWIN Richard",
"address": null,
"birth_date": null
},
"effective_date": "2015-09-01",
"evidence_quote": "DECIDE de prendre acte de la d\u00E9mission de Monsieur Richard ERWIN en tant qu\u0027Administrateur, Administrateur D\u00E9l\u00E9gu\u00E9 et Pr\u00E9sident du Conseil d\u0027Administration de la Soci\u00E9t\u00E9 avec effet au 1 septembre 2015.",
"discharge_granted": false
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "ERWIN Richard",
"address": null,
"birth_date": null
},
"effective_date": "2015-09-01",
"evidence_quote": "DECIDE de prendre acte de la d\u00E9mission de Monsieur Richard ERWIN en tant qu\u0027Administrateur, Administrateur D\u00E9l\u00E9gu\u00E9 et Pr\u00E9sident du Conseil d\u0027Administration de la Soci\u00E9t\u00E9 avec effet au 1 septembre 2015. L\u0027assembl\u00E9e donne d\u00E9charge \u00E0 l\u0027Administrateur D\u00E9l\u00E9gu\u00E9 pour sa gestion en 2015.",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GUILLAUME Arnaud",
"address": null,
"birth_date": null
},
"effective_date": "2015-09-01",
"evidence_quote": "DECIDE de nommer Monsieur Amaud GUILLAUME, avec r\u00E9sidence \u00E0 Groeselenberg 192, 1180 Uccle, Belgique, en tant qu\u0027 Administrateur et Pr\u00E9sident du Conseil d\u0027Administration de la Soci\u00E9t\u00E9 avec effet au 1 Septembre 2015 pour une dur\u00E9e d\u0027un (1) an."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}27-01-2015 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}2014
02-12-2014 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0403.088.151",
"name_full": "ROCHE",
"legal_form": "SA"
}
}First 30 of 44 acts
Credit advice
AI due-diligence brief
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Company registry (CBE)
Activities
Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen24421Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Groothandel in farmaceutische producten51460Vervaardiging van andere chemische producten, n.e.g.20590Vervaardiging van andere chemische producten, neg20590Vervaardiging van overige chemische producten24660
Primary activity highlighted.
Names & trade names
| Legal nameNL | ROCHE |
Registered office
Dantestraat 75
1070 Anderlecht, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies
A.forall Development
BE 0827.869.165 · Anderlecht
Ferring
BE 0428.038.135 · Anderlecht
LABORATOIRES SOPRELI
BE 0417.104.255 · Anderlecht
Laboratoires Sterop
BE 0408.238.752 · Anderlecht
NEOGEN
BE 0445.922.856 · Anderlecht